A detailed history of State Of New Jersey Common Pension Fund D transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 84,121 shares of NTLA stock, worth $1.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
84,121
Previous 85,826 1.99%
Holding current value
$1.2 Million
Previous $1.92 Million 10.0%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$19.72 - $27.36 $33,622 - $46,648
-1,705 Reduced 1.99%
84,121 $1.73 Million
Q2 2024

Aug 07, 2024

SELL
$20.02 - $27.22 $299,759 - $407,565
-14,973 Reduced 14.85%
85,826 $1.92 Million
Q1 2024

May 02, 2024

BUY
$23.82 - $32.8 $462,512 - $636,877
19,417 Added 23.86%
100,799 $2.77 Million
Q4 2023

Feb 02, 2024

BUY
$23.16 - $32.34 $395,619 - $552,431
17,082 Added 26.57%
81,382 $2.48 Million
Q2 2023

Aug 02, 2023

BUY
$34.58 - $46.03 $161,938 - $215,558
4,683 Added 7.86%
64,300 $2.62 Million
Q1 2023

Apr 26, 2023

BUY
$33.3 - $44.82 $430,502 - $579,432
12,928 Added 27.69%
59,617 $2.22 Million
Q4 2022

Feb 01, 2023

BUY
$33.21 - $62.69 $93,452 - $176,409
2,814 Added 6.41%
46,689 $1.63 Million
Q3 2022

Oct 28, 2022

SELL
$53.92 - $71.7 $200,043 - $266,007
-3,710 Reduced 7.8%
43,875 $2.46 Million
Q2 2022

Aug 04, 2022

BUY
$38.49 - $76.21 $285,018 - $564,335
7,405 Added 18.43%
47,585 $2.46 Million
Q4 2021

Jan 31, 2022

BUY
$100.76 - $138.36 $259,255 - $356,000
2,573 Added 6.84%
40,180 $4.75 Million
Q3 2021

Oct 27, 2021

SELL
$132.37 - $176.78 $444,763 - $593,980
-3,360 Reduced 8.2%
37,607 $5.05 Million
Q2 2021

Jul 23, 2021

BUY
$60.88 - $161.91 $406,739 - $1.08 Million
6,681 Added 19.49%
40,967 $6.63 Million
Q1 2021

Apr 27, 2021

BUY
$46.59 - $83.68 $1.6 Million - $2.87 Million
34,286 New
34,286 $2.75 Million

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.09B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.